Send Inquiry

Request To Call Back

Ranitidine HCL IP

Get a Price/Quote

MOQ : 100 Kilograms

Ranitidine HCL IP Specification

Poisonous
No (under therapeutic use)

Loss on Drying
NMT 0.5%

Shelf Life
5 Years

Boiling point
Not applicable (decomposes before boiling)

Molecular Weight
350.87 g/mol

Color
White to pale yellow

Structural Formula
Refer to certificate of analysis/supplied structure

HS Code
29420090

Molecular Formula
C13H22N4O3SHCl

Heavy Metal (%)
NMT 0.001%

Smell
Odorless

Storage
Store in a cool, dry place, protected from light

Melting Point
Varies, approx 134-140C

Ph Level
5.0 - 7.0 (1% solution)

EINECS No
266-565-6

Particle Size
As per requirement (typically 90% below 100 microns)

Solubility
Soluble in water, slightly soluble in alcohol

Taste
Bitter

Medicine Name
Ranitidine HCL IP

Chemical Name
N-(2-((5-[(Dimethylamino)methyl]furan-2-yl)methylthio)ethyl)-N-methyl-2-nitroethene-1,1-diamine hydrochloride

CAS No
66357-35-5

Type
API / Bulk Drug

Grade
IP (Indian Pharmacopoeia)

Usage
Used in treatment of ulcers and gastroesophageal reflux disease (GERD)

Purity(%)
98% Min

Appearance
White to pale yellow crystalline powder

Physical Form
Solid

Assay (on dried basis)
98.0%-102.0%

Related Substances
NMT 0.5%

Chloride Content
As per specification

Residual Solvents
Complies with IP

Identification
Complies with IP requirements

Packing Storage Condition
Protect from moisture and physical damage

Microbial Limit
Complies with IP

Packaging
Fibre drum with double polythene bags, net weight 25 kg

Ranitidine HCL IP Trade Information

Minimum Order Quantity
100 Kilograms

Supply Ability
1000 Kilograms Per Week

Delivery Time
7 Days

Ranitidine HCL IP About

Take advantage of this top-rated Ranitidine HCL IP, engineered to achieve optimum purity and efficacy. Complying with IP requirements, its extraordinary characteristics include a purity of 98.0%-102.0% (on dried basis), related substances NMT 0.5%, and strict adherence to residual solvent and microbial limit specifications. This distinguished white to pale yellow crystalline powder is ideal for the treatment of ulcers and GERD. Packaged in a robust 25 kg fibre drum with double polythene bags, it ensures enduring quality, provided storage instructions are followed. Last chance to secure this highly sought-after API at exceptional value from a leading Indian supplier.

Applications & Usage Scope of Ranitidine HCL IP

Ranitidine HCL IP is a versatile bulk drug, widely used in the pharmaceutical industry for the manufacture of oral dosage forms, emphasizing its role in managing stomach ulcers and gastroesophageal reflux disease (GERD). Beyond its principal applications, it is often integrated into research and development projects focusing on histamine-2 blocker therapies. Both large-scale production and small batch compounding benefit from its standardized particle size and reliable solubility profile.

Sample Policy, Delivery Time, and Packaging Details

Samples of Ranitidine HCL IP are provided under a clear Valuation policy and at the lowest price for domestic market evaluation. Typical delivery times are swift, aligning with supply chain commitments across India. Packaged with the utmost care in sturdy 25 kg fibre drums lined with double polythene bags, each batch is shielded against moisture and physical damage to maintain exceptional quality throughout transportation and storage.

FAQ's of Ranitidine HCL IP:

Q: How should Ranitidine HCL IP be stored to maintain its quality?

A: Ranitidine HCL IP should be stored in a cool, dry place, protected from light, moisture, and physical damage to preserve its integrity throughout its 5-year shelf life.

Q: What are the primary pharmaceutical applications of Ranitidine HCL IP?

A: Ranitidine HCL IP is primarily used for the treatment of ulcers and gastroesophageal reflux disease (GERD), and is commonly manufactured into oral dosage formulations.

Q: When can I expect delivery after placing an order for Ranitidine HCL IP?

A: Delivery times are typically fast and tailored to domestic market requirements. Exact timelines can be confirmed upon order placement, ensuring prompt supply to meet your needs.

Q: Where can I access the certificate of analysis or the structural formula?

A: The certificate of analysis, including the detailed structural formula for Ranitidine HCL IP, is supplied with each batch or available upon request from the manufacturer or distributor.

Q: What is the packaging specification for Ranitidine HCL IP shipments?

A: Each shipment is packaged in a 25 kg fibre drum with double polythene inner bags to provide optimum protection against moisture and physical hazards during transit and storage.

Q: How does Ranitidine HCL IP benefit pharmaceutical manufacturers?

A: Its extraordinary purity, compliance with IP standards, and consistent particle size make it highly reliable for pharmaceutical formulation, ensuring high-quality and safe finished products.

Tell us about your requirement